Current Protocols in Pharmacology, volume 44, issue 1

Overview of High‐Throughput Screening

Entzeroth Michael 1
Flotow Horst 1
Condron Peter 1
1
 
Experimental Therapeutics Centre, Agency for Science, Technology, and Research (A*STAR) Singapore
Publication typeJournal Article
Publication date2009-03-10
Quartile SCImago
Q1
Quartile WOS
Impact factor
ISSN19348282, 19348290
Pharmacology
Abstract
High‐throughput screening (HTS) is a key process used in drug discovery to identify hits from compound libraries that may become leads for medicinal chemistry optimization. This updated overview discusses the utilization of compound libraries, compounds derived from combinatorial and parallel synthesis campaigns and natural product sources; creation of mother and daughter plates; and compound storage, handling, and bar coding in HTS. The unit also presents an overview of established and emerging assay technologies (i.e., time‐resolved fluorescence, fluorescence polarization, fluorescence‐correlation spectroscopy, functional whole cell assays, and high‐content assays) and their integration in automation hardware and IT systems. This revised unit provides updated descriptions of state‐of‐the‐art instrumentation and technologies in this rapidly changing environment. The section on assay methodologies now also covers enzyme complementation assays and methods for high‐throughput screening of ion channel activities. Finally, a section on criteria for assay robustness is included discussing the Z′‐factor, which is now a widely accepted criterion for evaluation and validation of high throughput screening assays. Curr. Protoc. Pharmacol. 44:9.4.1‐9.4.27. © 2009 by John Wiley & Sons, Inc.

Citations by journals

1
2
3
SLAS Discovery
SLAS Discovery, 3, 6.82%
SLAS Discovery
3 publications, 6.82%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 2, 4.55%
International Journal of Molecular Sciences
2 publications, 4.55%
Current Medicinal Chemistry
Current Medicinal Chemistry, 2, 4.55%
Current Medicinal Chemistry
2 publications, 4.55%
Scientific Reports
Scientific Reports, 2, 4.55%
Scientific Reports
2 publications, 4.55%
Methods in Molecular Biology
Methods in Molecular Biology, 2, 4.55%
Methods in Molecular Biology
2 publications, 4.55%
Anti-Infective Agents
Anti-Infective Agents, 1, 2.27%
Anti-Infective Agents
1 publication, 2.27%
Molecules
Molecules, 1, 2.27%
Molecules
1 publication, 2.27%
Sensors
Sensors, 1, 2.27%
Sensors
1 publication, 2.27%
Antibiotics
Antibiotics, 1, 2.27%
Antibiotics
1 publication, 2.27%
Journal of Pharmaceutical Innovation
Journal of Pharmaceutical Innovation, 1, 2.27%
Journal of Pharmaceutical Innovation
1 publication, 2.27%
Journal of Cheminformatics
Journal of Cheminformatics, 1, 2.27%
Journal of Cheminformatics
1 publication, 2.27%
Drug Discovery Today
Drug Discovery Today, 1, 2.27%
Drug Discovery Today
1 publication, 2.27%
Acta Pharmaceutica Sinica B
Acta Pharmaceutica Sinica B, 1, 2.27%
Acta Pharmaceutica Sinica B
1 publication, 2.27%
Current Research in Biotechnology
Current Research in Biotechnology, 1, 2.27%
Current Research in Biotechnology
1 publication, 2.27%
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, 1, 2.27%
PLoS Neglected Tropical Diseases
1 publication, 2.27%
New Biotechnology
New Biotechnology, 1, 2.27%
New Biotechnology
1 publication, 2.27%
Medicinal Research Reviews
Medicinal Research Reviews, 1, 2.27%
Medicinal Research Reviews
1 publication, 2.27%
Journal of Biotechnology
Journal of Biotechnology, 1, 2.27%
Journal of Biotechnology
1 publication, 2.27%
Analytica Chimica Acta
Analytica Chimica Acta, 1, 2.27%
Analytica Chimica Acta
1 publication, 2.27%
Patterns
Patterns, 1, 2.27%
Patterns
1 publication, 2.27%
Cytometry. Part A : the journal of the International Society for Analytical Cytology
Cytometry. Part A : the journal of the International Society for Analytical Cytology, 1, 2.27%
Cytometry. Part A : the journal of the International Society for Analytical Cytology
1 publication, 2.27%
Current Protocols in Pharmacology
Current Protocols in Pharmacology, 1, 2.27%
Current Protocols in Pharmacology
1 publication, 2.27%
Advanced Energy Materials
Advanced Energy Materials, 1, 2.27%
Advanced Energy Materials
1 publication, 2.27%
Current Protocols in Stem Cell Biology
Current Protocols in Stem Cell Biology, 1, 2.27%
Current Protocols in Stem Cell Biology
1 publication, 2.27%
Clinical Pharmacology in Drug Development
Clinical Pharmacology in Drug Development, 1, 2.27%
Clinical Pharmacology in Drug Development
1 publication, 2.27%
RSC Advances
RSC Advances, 1, 2.27%
RSC Advances
1 publication, 2.27%
Journal of Cancer Prevention & Current Research, 1, 2.27%
Journal of Cancer Prevention & Current Research
1 publication, 2.27%
Expert Opinion on Drug Discovery
Expert Opinion on Drug Discovery, 1, 2.27%
Expert Opinion on Drug Discovery
1 publication, 2.27%
New Zealand Journal of Zoology
New Zealand Journal of Zoology, 1, 2.27%
New Zealand Journal of Zoology
1 publication, 2.27%
1
2
3

Citations by publishers

1
2
3
4
5
6
7
8
9
Elsevier
Elsevier, 9, 20.45%
Elsevier
9 publications, 20.45%
Springer Nature
Springer Nature, 7, 15.91%
Springer Nature
7 publications, 15.91%
Wiley
Wiley, 7, 15.91%
Wiley
7 publications, 15.91%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 5, 11.36%
Multidisciplinary Digital Publishing Institute (MDPI)
5 publications, 11.36%
Bentham Science
Bentham Science, 3, 6.82%
Bentham Science
3 publications, 6.82%
SAGE
SAGE, 3, 6.82%
SAGE
3 publications, 6.82%
Taylor & Francis
Taylor & Francis, 2, 4.55%
Taylor & Francis
2 publications, 4.55%
Public Library of Science (PLoS)
Public Library of Science (PLoS), 1, 2.27%
Public Library of Science (PLoS)
1 publication, 2.27%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 1, 2.27%
Royal Society of Chemistry (RSC)
1 publication, 2.27%
MedCrave Group Kft., 1, 2.27%
MedCrave Group Kft.
1 publication, 2.27%
Paediatrician Publishers LLC
Paediatrician Publishers LLC, 1, 2.27%
Paediatrician Publishers LLC
1 publication, 2.27%
Frontiers Media S.A.
Frontiers Media S.A., 1, 2.27%
Frontiers Media S.A.
1 publication, 2.27%
1
2
3
4
5
6
7
8
9
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Entzeroth M., Flotow H., Condron P. Overview of High‐Throughput Screening // Current Protocols in Pharmacology. 2009. Vol. 44. No. 1.
GOST all authors (up to 50) Copy
Entzeroth M., Flotow H., Condron P. Overview of High‐Throughput Screening // Current Protocols in Pharmacology. 2009. Vol. 44. No. 1.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1002/0471141755.ph0904s44
UR - https://doi.org/10.1002%2F0471141755.ph0904s44
TI - Overview of High‐Throughput Screening
T2 - Current Protocols in Pharmacology
AU - Entzeroth, Michael
AU - Flotow, Horst
AU - Condron, Peter
PY - 2009
DA - 2009/03/10 00:00:00
PB - Wiley
IS - 1
VL - 44
SN - 1934-8282
SN - 1934-8290
ER -
BibTex
Cite this
BibTex Copy
@article{2009_Entzeroth,
author = {Michael Entzeroth and Horst Flotow and Peter Condron},
title = {Overview of High‐Throughput Screening},
journal = {Current Protocols in Pharmacology},
year = {2009},
volume = {44},
publisher = {Wiley},
month = {mar},
url = {https://doi.org/10.1002%2F0471141755.ph0904s44},
number = {1},
doi = {10.1002/0471141755.ph0904s44}
}
Found error?